跳至主要内容
临床试验/NCT07471308
NCT07471308进行中(未招募)不适用

Validation of an Algorithm Designed to Predict the Recurrence of AF After Pulmonary Vein Isolation Using P-wave Duration and Procedural Unipolar Atrial Local Potential Measurements

CathVision ApS1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年4月13日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
1
主要终点
Primary Objective

研究概览

简要总结

Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia worldwide and is associated with substantial morbidity, mortality, and healthcare utilization. Catheter ablation, most commonly pulmonary vein isolation (PVI), is an established rhythm control strategy for AF4.

Despite technological advances and the emergence of pulse field ablation (PFA), long-term AF recurrence after a first ablation procedure remains frequent, occurring in approximately 30-50% of patients5. Post-ablation follow-up strategies, including visit frequency, rhythm monitoring intensity, and Antiarrhythmic Drug management, vary widely across providers and institutions and are largely guided by subjective assessment rather than objective, science-based recurrence risk estimation6. In parallel, asymptomatic (silent) AF recurrence is exacerbated following ablation, limiting the reliability of symptom-driven follow-up7.

FOLLOW-AF is a retrospective, observational cohort study designed to validate the FollowGenius algorithm and evaluate the diagnostic performance in predicting AF recurrence based on atrial remodeling and vein isolation.

The cohort will be patients with paroxysmal or persistent AF who underwent PVI with the PFA modality.

详细描述

Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia worldwide and is associated with substantial morbidity, mortality, and healthcare utilization.3 Catheter ablation, most commonly pulmonary vein isolation (PVI), is an established rhythm control strategy for symptomatic AF.4 Historically, this has been achieved using radiofrequency and thermal energy. However, more recently a new energy source known as pulsed field ablation (PFA) has been introduced. As PFA is tissue selective, it preserves the function of nearby structures such as the esophagus and phrenic nerve making it safer to use. As PFA is delivered in short bursts of high energy, it is also more efficient and leads to shorter procedures.

Despite technological advances and the emergence of pulse field ablation (PFA), long-term AF recurrence after a first ablation procedure remains frequent, occurring in approximately 30-50% of patients.5 Post-ablation follow-up strategies, including visit frequency, rhythm monitoring intensity, and anticoagulation management, vary widely across providers and institutions and are largely guided by subjective assessment rather than objective, science-based recurrence risk estimation.6 In parallel, asymptomatic (silent) AF recurrence is exacerbated following ablation, limiting the reliability of symptom-driven follow-up.7

The underlying causes of AF recurrence are broadly driven by two distinct, yet complementary, mechanisms:

  1. Atrial Substrate Modification (Remodeling): Many patients have pre-existing atrial myopathy or remodeling due to long-standing hypertension, heart failure, or AF itself. This "diseased substrate" is prone to initiating and sustaining new AF triggers outside the pulmonary veins. P-wave duration, a simple, non-invasive marker from the surface ECG, is a well-established surrogate for this electrical and structural remodeling.2,9,10
  2. PVI Isolation (Reconnection): The primary goal of ablation is to create durable, transmural lesions to isolate the pulmonary veins. If lesions are incomplete, electrical reconnection often occurs, allowing the original AF triggers to re-initiate arrhythmia. Residual local potentials measured during the ablation procedure are a suggested marker of incomplete lesion formation, predicting non-durability.1,11,12

Pulmonary vein isolation status is acquired by measuring the intra-cardiac residual electrical activity (local potential) in the vein, after PFA application. Residual local potentials will be extracted by the PF Analyzer module of the ECGenius™ System. Isolation status is defined based on thresholds from literature.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 21 years
  • Paroxysmal or persistent atrial fibrillation
  • Underwent pulmonary vein isolation using pulse field ablation
  • Patient record with pre-/post-ablation 12-lead ECGs and intra-procedural unipolar electrograms

排除标准

  • Incomplete patient record:
  • Lack of 12-leads ECG recording or intracardiac electrograms
  • Lack of post-procedure follow-up assessment
  • Follow-up was less than 6 months
  • Cardiac recording data incomplete or not of sufficient quality
  • Cardiac anatomical variation such as Left Common, or Right Accessory

研究组 & 干预措施

Cohort 1 - Continuous monitoring

Subject with continuous post-procedure monitoring, such as ILR, pacemaker, and CRT device

干预措施: AF Recurrence RIsk Assessment post pulmonary vein isolation (Device)

Cohort 2 - Transient monitoring

Subject with transient monitoring, such as Holter, and tracking devices

干预措施: AF Recurrence RIsk Assessment post pulmonary vein isolation (Device)

Cohort 3 - Punctual monitoring

Subject with punctual monitoring, such as reported symptoms during physician visit

干预措施: AF Recurrence RIsk Assessment post pulmonary vein isolation (Device)

结局指标

主要结局

Primary Objective

时间窗: 6 months

Evaluate predictive performance of a novel prognostic algorithm (called FollowGenius) combining p-wave duration and procedural unipolar atrial local potential measurements in predicting recurrence of AF after pulmonary vein isolation using PFA.

次要结局

  • Secondary Objective(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验